MD Anderson spotlights role of cytokine in tumor progression

There's a well-known link between the activation of epidermal growth factor receptors (EGFR) and tumor progression. Now scientists at MD Anderson in Texas can be shut down with the help of a cytokine called macrophage migration inhibitory factor, or MIF. "MIF can be secreted from both tumor and immune cells," said Zhimin Lu, M.D., Ph.D., professor of Neuro-Oncology. "Importantly, secreted MIF is modified by an attached sugar group which allows MIF to gain a specific new function compared to its non-modified form." Release

Suggested Articles

Dutch scientists used stem cells from CF patients to demonstrate a technique that corrects a mutation in the gene CFTR without having to cut DNA.

A new map of the thymus gland could help researchers understand how T cells develop and inspire treatments for cancer and autoimmune disease.

Brigham and Women’s Hospital scientists linked a noncoding RNA to atherosclerosis in a discovery that could aid in the development of new heart drugs.